Abstract
Information concerning drug interactions is essential for physicians and patients when attempting to limit the number of serious adverse events. This information, however, is generally the result of research initiated by pharmaceutical companies and regulatory authorities, and as such not aimed at the needs of either physician or patient. This article carefully assesses these needs and intends to provide guidance in order to improve the current situation. To this end a number of practical examples of drug interaction are re-evaluated in terms of their informative utility.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have